Errors: In the Original Contribution entitled “Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention,” published in the March 16, 2011, issue of JAMA (2011;305:1097-1105), data in a figure were misplaced, a conflict of interest statement was omitted, and Dr Stillabower's name was misspelled.
The hazard ratios in Figure 2 were placed in the wrong panels. Dr Topol's conflict of interest statement should have read: “Dr Topol reported receiving consulting fees from Bristol-Myers Squibb/sanofi-aventis and Daiichi Sankyo/Lilly & Co.”
Error in: Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention. JAMA. 2011;305(21):2174. doi:10.1001/jama.2011.711